Correlation Between Adagene and Alzamend Neuro
Can any of the company-specific risk be diversified away by investing in both Adagene and Alzamend Neuro at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adagene and Alzamend Neuro into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adagene and Alzamend Neuro, you can compare the effects of market volatilities on Adagene and Alzamend Neuro and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adagene with a short position of Alzamend Neuro. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adagene and Alzamend Neuro.
Diversification Opportunities for Adagene and Alzamend Neuro
-0.77 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Adagene and Alzamend is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding Adagene and Alzamend Neuro in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alzamend Neuro and Adagene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adagene are associated (or correlated) with Alzamend Neuro. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alzamend Neuro has no effect on the direction of Adagene i.e., Adagene and Alzamend Neuro go up and down completely randomly.
Pair Corralation between Adagene and Alzamend Neuro
Given the investment horizon of 90 days Adagene is expected to generate 0.44 times more return on investment than Alzamend Neuro. However, Adagene is 2.3 times less risky than Alzamend Neuro. It trades about 0.08 of its potential returns per unit of risk. Alzamend Neuro is currently generating about -0.1 per unit of risk. If you would invest 162.00 in Adagene on May 4, 2025 and sell it today you would earn a total of 30.00 from holding Adagene or generate 18.52% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Adagene vs. Alzamend Neuro
Performance |
Timeline |
Adagene |
Alzamend Neuro |
Adagene and Alzamend Neuro Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Adagene and Alzamend Neuro
The main advantage of trading using opposite Adagene and Alzamend Neuro positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adagene position performs unexpectedly, Alzamend Neuro can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alzamend Neuro will offset losses from the drop in Alzamend Neuro's long position.Adagene vs. Anebulo Pharmaceuticals | Adagene vs. Jade Biosciences, | Adagene vs. Acrivon Therapeutics, Common | Adagene vs. AN2 Therapeutics |
Alzamend Neuro vs. Synlogic | Alzamend Neuro vs. AC Immune | Alzamend Neuro vs. Context Therapeutics | Alzamend Neuro vs. Ensysce Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |